Skip to content
Stock screener

AORT Artivion, Inc. stock chart & analysis

Conviction 18HealthcareScan · Fri, Nov 6, 2026
Bearish belt hold

Artivion, Inc. (AORT) closed at $20.21 (-20.21%) on Nov 6, 2026. Its latest daily candle is a bearish belt hold. Price is below its 50-day and below its 200-day moving average. RSI(14) 38, RS Rating 11, -58.1% from its 52-week high, -55.7% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

AORT$20.21-20.21%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Artivion, Inc.Surgical & Medical Instruments & Apparatuswww.artivion.com ↗
Price20.21
Change-20.21%
Gap-9.99%
Rel volume6.96×
Avg volume733.24K
Avg $ vol16.52M
SMA 2022.90
SMA 5023.55
SMA 20028.89
Price vs 50-14.18%
Price vs 200-30.05%
MA stackbearish
50/200 cross—
Supertrenddown · 26.51
RSI (14)38
MACD hist0.07
MACD cross—
Stoch %K / %D6 / 57
ADX (14)22
+DI / −DI23 / 33
RSI divergence—
MACD divergence—
ATR %7.63%
ADR %5.08%
52w high48.25
52w low19.16
From 52w high-58.11%
Above 52w low+5.48%
New 52w highNo
SqueezeOff
Bollinger width23.69%
%B0.00
Donchian pos6.34%
Donchian high27.00
Donchian low19.75
AVWAP (52w high)28.23
vs AVWAP high-28.41%
AVWAP (52w low)23.92
vs AVWAP low-15.49%
OBV trendDown
Chaikin MF (20)-0.19
Today vs 20d6.96×
Avg vol (14d)833.13K
Avg vol (20d)733.24K
Avg $ vol (20d)16.52M
Market cap986.04M
RS Rating11 / 99
RS 3m (vs SPY)-18.32%
RS 6m (vs SPY)-20.16%
RS line new highNo
Trend template0/8
Technical rank25.6
1 week-10.50%
1 month-4.71%
3 months-23.19%
6 months-20.46%
1 year-56.55%
YTD-55.69%
P/E100.95
P/B2.21
P/S2.23
P/FCF1175.26
EPS0.2100
Div yield0.35%
ROE2.19%
ROA0.94%
Debt/Eq0.81
Current4.42
EV/EBITDA23.16
Gross margin64.40%
Net margin2.21%
Rev growth13.59%
EPS growth173.12%
Price target38.65
Target upside91.24%
Analyst ratingBuy
Institutional102.40%
Ent. value1.3B
Revenue123.79M
Net income-7.93M
Gross profit75.98M
Free cash flow839K
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNYSE
Shares out48.54M
Employees1.8K
ListedThu, Feb 11, 1993
Free float45.46M
Float %93.8%
Short interest—
Days to cover—
Short volume37.4%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$0.08 vs $0.11
Last surprise-27.3% miss
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank25.6 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish belt hold

Financials as of Wed, Sep 30, 2026 · quarterly.

AORT technical analysis

Trend

AORT is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 14.2% below the 50-day ($23.55) and 30.0% below the 200-day ($28.89). ADX(14) at 22 points to a moderate trend. It meets 0 of 8 trend-template criteria.

Momentum

RSI(14) is 38, in the bearish half of its range. The MACD histogram is positive. Its RS Rating of 11 puts its weighted 12-month performance ahead of about 11% of the US market.

Volume and volatility

Volume on the latest session ran 7.0× its 20-day average. It trades about $16.5M a day on average. ATR(14) is $1.54, 7.6% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.19) shows distribution.

Key levels

The 52-week range is $19.16 to $48.25; price is 58.1% below the high and 5.5% above the low. The VWAP anchored at the 52-week high is $28.23, above price.

Performance

AORT returned -10.5% (1 week), -4.7% (1 month), -23.2% (3 months), -20.5% (6 months), -56.5% (1 year), -55.7% (year to date).

About Artivion, Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Surgical & Medical Instruments & Apparatus · Listed 1993 · 1,800 employees

Recent news

Congress activity

Disclosed STOCK Act trades in AORT · 2 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-08-20
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-07-16
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in AORT · open-market 5 sells

InsiderSideShares
GREEN ANDREW M
SVP, Regulatory and Quality · Common Stock · 2026-09-10
Sell11.48K
Mackin James P
President & CEO · Common Stock · 2026-08-19
Sell70K
Berry Lance A
EVP, COO, CFO & Treasurer · Common Stock · 2026-08-14
Sell715
GREEN ANDREW M
SVP, Regulatory and Quality · Common Stock · 2026-08-14
Sell616
Holloway Jean F
SVP, General Counsel · Common Stock · 2026-08-12
Sell977
SEMEDO ANTHONY B.
Director · Common Stock · 2026-06-02
Acquire6.33K
SEMEDO ANTHONY B.
Director · Common Stock · 2026-06-02
Other—
SEMEDO ANTHONY B.
Director · Common Stock · 2026-06-02
Dispose6.33K
SEMEDO ANTHONY B.
Director · Common Stock · 2026-05-18
Grant7.58K
Salveson Jon W
Director · Common Stock · 2026-05-18
Grant7.58K

SEC filings

EDGAR filings in AORT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.